Surgical Risk Assessment in Aortic Dissection: The New German Tool
Validation of the perioperative risk prediction system for patients undergoing type A aortic dissection repair derived from the GERAADA German registry.
Validation of the perioperative risk prediction system for patients undergoing type A aortic dissection repair derived from the GERAADA German registry.
A retrospective analysis was conducted to evaluate the evolution and outcomes of cardiac surgery in patients with prior TAVI, utilizing data from the STS database from 2012 to 2023.
This literature review revisits the pathophysiological principles of ischemia, reperfusion, and myocardial ischemia tolerance, as well as the concepts of myocardial protectioN and the main evidence on outcomes among different cardioplegia solutions retrospectively since 2020.
Five-year results from the PARTNER 3 trial, which evaluated the balloon-expandable SAPIEN 3® TAVI versus surgical aortic valve replacement (SAVR) in low-risk patients.
Dr. Encarnación Gutiérrez’s review discusses the current state of managing infections associated with cardiac stimulation devices (CSDs), addressing the increase in associated costs due to three primary factors.
A retrospective study conducted by Yale University over three decades scrutinizes the data from its Aortic Institute to assess the validity of surgical indications for rapid growth exceeding 3 mm/year.
A retrospective study conducted in the United States analyzed the incidence, outcomes, and costs associated with heparin-induced thrombocytopenia (HIT) in patients undergoing cardiac surgery.
This retrospective study evaluates the frequency and clinical impact of thromboembolic complications following aortic arch repair utilizing the Frozen Elephant Trunk (FET) with the Thoraflex® device (Terumo Aortic®).
This study, conducted at a tertiary pediatric cardiology center, evaluates the long-term use of ventricular assist devices (VADs).
This single-center retrospective study analyzes the clinical and safety outcomes of leadless pacemakers in patients requiring permanent pacing after cardiac surgery or transcatheter valve intervention.